To include your compound in the COVID-19 Resource Center, submit it here.

On Human Origins

Court decisions last week in the U.S. related to patent infringement litigation between MorphoSys AG and Cambridge Antibody Technology Group plc leave nothing resolved, although they do place all three suits between the parties in the same court. And while a preliminary ruling in the "Griffiths" patent suit appeared to favor MOR, CAT said its freedom to operate is not in jeopardy.

Last week's action in the U.S. District Court for the District of Columbia involved a

Read the full 768 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers